Drug intelligence / Profile preview

Same Nicotine Content Cigarettes

Development stage
Unknown
Lead developer
Milton S Hershey Medical Center
Modality
Small Molecules
Administration
Inhalation
01

Overview

Same Nicotine Content Cigarettes refer to the control arm intervention in clinical research conducted by the Milton S. Hershey Medical Center (Penn State) investigating tobacco dependence. These research-grade cigarettes, typically from the SPECTRUM line, contain a standardized 'usual' nicotine level of approximately 11.6 mg per cigarette. They are used as a comparator against Reduced Nicotine Content (RNC) cigarettes to evaluate whether tapering nicotine levels can reduce dependence in smokers, particularly those from low socioeconomic backgrounds. The active component, nicotine, is a small molecule that functions as an agonist at nicotinic acetylcholine receptors (nAChRs), primarily the alpha-4-beta-2 subtype, which mediates the addictive properties of tobacco through the mesolimbic dopamine pathway. This research is part of tobacco regulatory science aimed at informing potential FDA regulations on nicotine levels in commercial tobacco products.

Brand names
SPECTRUM
Other names
Research cigarettes11.6 mg nicotine cigarettesSame Nicotine Content Cigarettes-Milton S. Hershey Medical Center-tobacco dependence
02

Targets

CHRNA7 (α7 nicotinic receptor)α4β2 nAChR (Nicotinic acetylcholine receptor alpha4 beta2 subtype)

Beyond the preview

Go deeper on Same Nicotine Content Cigarettes.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Same Nicotine Content Cigarettes.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call